| Clinical presentation, treatment and outcome of anaplastic thyroid carcinoma: results of a multicenter study in Germany J Wendler, M Kroiss, K Gast, MC Kreissl, S Allelein, U Lichtenauer, ... European journal of endocrinology 175 (6), 521-529, 2016 | 114 | 2016 |
| Objective response and prolonged disease control of advanced adrenocortical carcinoma with cabozantinib M Kroiss, F Megerle, M Kurlbaum, S Zimmermann, J Wendler, C Jimenez, ... The Journal of Clinical Endocrinology & Metabolism 105 (5), 1461-1468, 2020 | 62 | 2020 |
| High-dose chemotherapy and autologous stem cell transplant in elderly patients with primary CNS lymphoma: a pilot study E Schorb, B Kasenda, G Ihorst, F Scherer, J Wendler, L Isbell, H Fricker, ... Blood advances 4 (14), 3378-3381, 2020 | 38 | 2020 |
| Effects on survival of non-myeloablative chemoimmunotherapy compared to high-dose chemotherapy followed by autologous stem cell transplantation (HDC-ASCT) as consolidation … G Illerhaus, AJM Ferreri, M Binder, P Borchmann, J Hasenkamp, ... Blood 140 (Supplement 2), LBA-3-LBA-3, 2022 | 18 | 2022 |
| Bone metastases in medullary thyroid carcinoma: high morbidity and poor prognosis associated with osteolytic morphology T Vogel, J Wendler, K Frank-Raue, MC Kreissl, C Spitzweg, M Fassnacht, ... The Journal of Clinical Endocrinology & Metabolism 105 (6), e2239-e2246, 2020 | 12 | 2020 |
| High-dose chemotherapy and autologous stem cell transplant in elderly and fit primary CNS lymphoma patients-a multicenter study by the cooperative PCNSL study group (MARTA study) E Schorb, L Isbell, A Kerkhoff, S Mathas, F Braulke, G Egerer, A Roeth, ... Blood 140 (Supplement 1), 1773-1774, 2022 | 9 | 2022 |
| Optimizing MATRix as remission induction in PCNSL: de-escalated induction treatment in newly diagnosed primary CNS lymphoma J Wendler, CP Fox, E Valk, C Steinheber, H Fricker, LK Isbell, S Neumaier, ... BMC cancer 22 (1), 971, 2022 | 4 | 2022 |
| High-dose chemotherapy and autologous haematopoietic stem-cell transplantation in older, fit patients with primary diffuse large B-cell CNS lymphoma (MARTA): a single-arm … E Schorb, LK Isbell, A Kerkhoff, S Mathas, F Braulke, G Egerer, A Röth, ... The Lancet Haematology 11 (3), e196-e205, 2024 | 1 | 2024 |
| Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS … LK Isbell, R Uibeleisen, A Friedl, E Burger, T Dopatka, F Scherer, A Orban, ... BMC cancer 23 (1), 767, 2023 | 1 | 2023 |
| Klinische Präsentation, Prognose und Therapie des anaplastischen Schilddrüsenkarzinoms–Entwurf und Auswertung einer multizentrischen Registerstudie JS Wendler Universität Würzburg, 2019 | 1 | 2019 |
| Clinical presentation, treatment and outcome of anaplastic thyroid carcinoma in Germany: a retrospective multi-center study J Wendler, M Kroiss, K Gast, M Kreissl, S Allelein, U Lichtenauer, R Blaser, ... Endocrine Abstracts 41, 2016 | 1 | 2016 |
| Geriatric assessment scores: Predictors of prognosis and premature end of treatment in the MARTA and MARiTA study population of elderly PCNSL patients> 65 years LK Isbell, A Vreden, G Ihorst, R Uibeleisen, A Friedl, A Orban, N Malenica, ... Hematological Oncology 41, 407-408, 2023 | | 2023 |
| CONSOLIDATIVE HCT‐ASCT IS SUPERIOR TO NON‐MYELOABLATIVE CHEMO‐IMMUNOTHERAPY IN NEWLY‐DIAGNOSED PCNSL‐UPDATED RESULTS OF THE RANDOMIZED PHASE III MATRIX/IELSG43 TRIAL G Illerhaus, A Ferreri, M Binder, P Borchmann, J Hasenkamp, ... Hematological Oncology 41, 41-43, 2023 | | 2023 |
| Age-adapted High-dose Therapy and autologous Stem Cell Transplantation in elderly Patients with Initial Diagnosis of primary CNS Lymphoma-The Phase II MARTA Study E Schorb, L Isbell, A Kerkhoff, S Mathas, F Braulke, G Egerer, A Roeth, ... ONCOLOGY RESEARCH AND TREATMENT 45 (SUPPL 2), 59-59, 2022 | | 2022 |
| Additional file 1 of Optimizing MATRix as remission induction in PCNSL: de-escalated induction treatment in newly diagnosed primary CNS lymphoma J Wendler, CP Fox, E Valk, C Steinheber, H Fricker, LK Isbell, S Neumaier, ... Figshare, 2022 | | 2022 |
| Objective response and prolonged stable disease in refractory adrenocortical carcinoma treated with cabozantinib: An international case series and protocols of phase II … M Kroiss, F Megerle, J Wendler, C Jimenez, M Quinkler, U Malzahn, ... Journal of Clinical Oncology 37 (15_suppl), e16118-e16118, 2019 | | 2019 |
| Towards a registry for rare malignant tumors of the thyroid J Wendler, K Gast, R Blaser, KA Kuhn, M Fassnacht, C Spitzweg, M Kroiss Experimental and Clinical Endocrinology & Diabetes 122 (03), P151, 2014 | | 2014 |
| High-Dose Chemotherapy and Autologous Stem Cell Transplant in Elderly and Fit PCNSL Patients–The Multicenter MARTA Study E Schorb, LK Isbell, A Kerkhoff, S Mathas, F Braulke, G Egerer, A Röth, ... | | |
